Related by context. All words. (Click for frequent words.) 67 FDA Approvable Letter 63 FDA Complete Response 62 Complete Response Letter CRL 62 Complete Response 62 PDUFA Date 62 Expedited Review 61 Supplemental Biologics License Application 61 Complete Response letter 61 FDA approvable letter 61 Paragraph IV Notice 61 Biologic License Application 61 Marketing Authorisation Application 61 Paragraph IV Certification 60 Generic Version 60 Resubmission 60 Drug Application 60 Barr ANDA 60 Patent Reexamination 59 FDA Accepts 59 approvable letters 59 Paragraph IV 59 Certiorari 59 Anchen Pharmaceuticals Inc. 59 Marketing Authorization 59 Defendants Motion 59 Announces Tentative Approval 58 Complete Response Letter 58 SR NYSEArca 58 Marketing Authorisation 58 Approvable Letter 58 Approvable 58 Drug Submission 58 BRILINTA 57 PMA Supplement 57 Patent Infringement Litigation 57 Preliminary Injunction 57 Warning Letter 57 Defendant Motion 57 National Coverage Determination 57 ANDA applicant 57 Mylan Receives Approval 57 Actavis Elizabeth 57 Plaintiff Motion 57 Novel Antibiotic 56 Paragraph IV certification 56 Receives Approvable Letter 56 Generic Lovenox 56 FDA Advisory Panel 56 Kynapid 56 GRAS notification 56 Product Characteristics 56 Accelerated Approval 56 Product Monograph 56 Preliminary Injunction Against 56 CERVARIX R 55 Product Designation 55 Declaratory Judgment 55 generic Copaxone 55 NASDAQ Listing Qualification 55 Biologic License Application BLA 55 Orapred ODT 55 Markman Hearing 55 GPhA 55 Nasdaq Delisting 55 Pending Litigation 55 Receives Complete Response 55 Therasense 55 Impax Labs 55 en banc rehearing 55 Transcept Pharmaceuticals 55 Rehearing En Banc 55 NASDAQ SHPGY 55 Not Approvable 55 Proposed Settlement 55 supplemental biologics 55 Generic Protonix 55 Patent Infringement Lawsuit 55 Amicus Brief 55 balsalazide tablet 55 Testosterone Gel 55 NASDAQ Listing 55 Amended Motion 55 Romiplostim 55 Generic Version Of 55 Submits NDA 55 Hatch Waxman Amendments 55 Reply Brief 54 Joint Stipulation 54 reh'g 54 Omnitrope 54 Cabilly patent 54 Defendants Motions 54 Weight Loss Drug 54 Biological License Application 54 PMPRB 54 Tamoxifen Citrate 54 Rehearing 54 Ticagrelor 54 Expanded Indication 54 Receives Tentative FDA 54 First Amended Complaint 54 Patent Lawsuit 54 Generic Versions 54 Counterclaims 54 Anidulafungin 54 Approvable letter 54 Linjeta 54 Fampridine SR NDA 54 Biologics License Application 54 Purepac 54 Biologics License Application BLA 54 Premarket Approval Application 54 Shareholder Proposals 54 approvability 54 NasdaqCM RPRX today 54 Pre IND 54 Plaintiffs Complaint 54 SmPC 54 Receives FDA Approvable 53 Emezine 53 Files Investigational 53 Inhaled Insulin 53 FDAs 53 Intermezzo ® NDA 53 IND Investigational New 53 Horizant ™ 53 Position Statement 53 Final Appraisal Determination 53 Menaflex implant 53 premarket notification 53 OTC IPXL 53 Oporia 53 Amicus Briefs 53 ANDA Filing 53 Psoriasis Drug 53 Lilly Evista 53 reexamination proceeding 53 NASDAQ Delisting 53 FDA 53 Nasdaq IPXL 53 FDA Anti Infective 53 pediatric exclusivity 53 Contrave NDA 53 Risperidone Oral Solution 53 Consent Judgment 53 k Premarket Notification 53 v. Siracusano 53 Schizophrenia Drug 53 Whistleblower Lawsuit 53 Patent Validity 53 Teva Provides Update 53 NASDAQ Hearings Panel 53 PUBPAT 53 SEASONALE 53 Stem Cell Patents 53 Arthritis Drug 53 Marketing Authorization Application 53 CHMP Opinion 53 Orathecin 53 NASDAQ Delisting Notice 53 Formal Dispute Resolution 53 Lilly Strattera 53 Alogliptin 53 rehearing en banc 53 Ustekinumab 53 Velaglucerase Alfa 53 Xenazine ® 53 Glatiramer Acetate 53 Surfaxin lucinactant 53 Plaintiff Complaint 53 Submits Supplemental 53 Drug Approvals 53 ANDA filer 53 Caraco Pharma 53 Issues Complete Response 53 Par Pharmaceuticals 53 FDA Oncologic Drugs 53 Pixuvri 53 AstraZeneca Toprol 53 Partial Summary Judgment 53 Zensana 53 Interim Injunction 53 NDA Submission 53 Second Amended Complaint 52 Levothyroxine Sodium 52 ECLJ 52 Nasdaq Delisting Notification 52 DDMAC 52 Lupin Pharmaceuticals Inc. 52 Amlodipine Besylate 52 Silenor NDA 52 Entocort 52 NexMed Receives 52 Bruesewitz v. 52 Confirms Patent 52 Patent Upheld 52 Receives Tentative Approval 52 BioDelivery Sciences 52 Patent Infringement Action 52 Resale Registration Statement 52 pantoprazole sodium 52 FDAAA 52 Clinical Trial Data 52 Voluntary Dismissal 52 Unsolicited Proposal From 52 Dexilant 52 Bayer Xarelto 52 Permanent Injunction 52 Orphan Designation 52 Unsolicited Proposal 52 Enjuvia 52 Nebivolol 52 Summary Judgment Order 52 BLA filing 52 IND Application 52 Cholesterol Drug 52 OHRP 52 ULTRASE 52 Marketing Authorisation Application MAA 52 ANDA Abbreviated New 52 CIP TRAMADOL ER 52 Dkt. No. 52 Indevus Pharma 52 Gout Drug 52 AIDAC 52 Plaintiffs Appellees 52 Morphine Sulfate 52 Cobalt Pharmaceuticals 52 Amended Notice 52 Drug Submission NDS 52 Polymer Microspheres 52 PLAVIX ® 52 APF# NDA 52 LibiGel ® 52 Pirfenidone 52 Epilepsy Drug 52 Submits Investigational 52 Salix Pharma 52 lorcaserin NDA 52 Synerx Pharma 52 Clinical Trial Application 52 Cellegesic 52 Ortho Cept 52 Declaratory Order 52 Ephedra Ban 52 SEASONALE R 52 Order Granting 52 generic Lipitor 52 Lilly Cymbalta 52 Bupropion HCl ER 52 Paragraph IV certifications 52 Positive Opinion 52 Voraxaze 52 Investigational Compound 52 inspectional observations 52 Sanvar 52 Anti Infective Drugs 52 sumatriptan injection 52 Summary Judgment 52 SPJSF 52 Nasdaq Listing Qualification 52 Investigational Agent 51 Trobalt 51 subsidiary Barr Laboratories 51 ZEGERID Chewable Tablets 51 Combating Counterfeit Drugs 51 supplemental Biologics License Application 51 Zegerid OTC 51 Sumatriptan Succinate Tablets 51 WHO prequalification 51 FDA Dermatologic 51 Marketing Authorization Applications 51 Optimer Pharma 51 Impax generic 51 sBLA filings 51 Drug Applications ANDAs 51 Deficiency Letter 51 FDA Issues Approvable 51 ASACOL 51 Praecis 51 Velac 51 IND Filing 51 Patent Infringement Suit 51 Stedesa 51 Certriad 51 Desvenlafaxine 51 Preliminary Proxy 51 casopitant 51 CONBRIZA 51 sBLA 51 Package Insert 51 approvable letter 51 Novartis Galvus 51 Tamsulosin 51 JMOL 51 Pennsaid R 51 Requester 51 Centralized Procedure 51 Ultracet R 51 Dkt 51 Amended Complaint 51 Viviant 51 application sNDA 51 ANDA containing 51 Regulatory Clearance 51 ANPRM 51 GRAS Status 51 InvaGen 51 NASDAQ IPXL today 51 Nasdaq Hearings Panel 51 Patent Ruling 51 Inequitable Conduct 51 Cholesterol Lowering Drug 51 Fortical R 51 PIX# [002] 51 bioequivalent versions 51 Teva Pharma 51 Master File DMF 51 Topiramate Tablets 51 Purported Class 51 Pulmonary Allergy Drugs 51 Favorable Ruling 51 Epilepsy Drugs 51 Voluntary Withdrawal 51 Nasdaq Listings Qualification 51 Loxapine 51 Counterclaim 51 Temporary Injunction 51 Premarket Approval 51 Final Approval 51 Angiox ® 51 IPXL 51 Oracea TM 51 Launches Generic Version 51 Authorized Generic 51 FDA Panel Recommends 51 Full Prescribing Information 51 Montelukast 51 Synthon 51 TSX SHQ 51 Seasonal Influenza Vaccine 51 En Banc 51 Fondaparinux 51 Anemia Drug 51 Amphastar 51 REMOXY NDA 50 Patent Lawsuit Against 50 Receive Milestone Payment 50 DATES Comments 50 Final Determination 50 KSR Int'l Co. 50 Fast Track Status 50 Emergency Contraceptive 50 Formal Complaint 50 Pa.RAP 50 Files IND 50 Stavzor 50 Premarket Approval PMA 50 responsive pleadings 50 Staff Determination Letter 50 Betaseron ® 50 LibiGel NDA 50 NOMAC E2 50 Acne Drug 50 Genpharm 50 Marketing Authorization Application MAA 50 NASDAQ Listing Requirements 50 Memorandum Opinion 50 Testosterone Patch 50 Tentative Approval 50 Requip XL 50 Files Voluntary 50 Horizant 50 Onsolis 50 Recommends Approval 50 Anchen 50 Patient Enrollment 50 nasal calcitonin product 50 Declaratory Judgment Act 50 patent invalidity 50 European Medicines Evaluation 50 Nasdaq SPPI 50 Shelf Registration Statement 50 NDA resubmission 50 assigned PDUFA 50 NYSE BRL 50 Hormone Therapy 50 Scheduling Order 50 NDPSC 50 Arthritis Drugs 50 Retacrit 50 Levetiracetam Tablets 50 FDA GRAS 50 Reorganization Plan 50 Derivative Action 50 Derivative Lawsuit 50 ISO Vorin TM 50 Files Provisional 50 solifenacin succinate 50 summary judgment motions 50 Phase 1b Clinical Trial 50 Liability Lawsuits 50 Fairness Hearing 50 Subpart H 50 rolling Biologics License 50 Amended Petition 50 Amended Judgment 50 Glucophage XR 50 Febuxostat 50 Psychopharmacologic Drugs Advisory 50 Stronger Warnings 50 Proposed Rule Making NPRM 50 sNDA 50 Cervical Cancer Vaccine 50 Orphan Status 50 T Pred 50 rasagiline tablets 50 Xinlay 50 Vioxx Successor 50 Unsolicited Tender Offer 50 Teva Pharmaceuticals USA 50 Nasdaq Delisting Notice 50 Propoxyphene 50 Confirmatory Phase 50 Extina 50 CHMP 50 metoprolol succinate 50 Acquisition Proposal 50 Application BLA 50 Submits Response 50 Justice Jamadar 50 Markman Ruling 50 Similac Formula 50 sub nom 50 Cefdinir 50 AMEX IVX LSE IVX.L 50 Amex PME 50 Phase III Clinical Trial 50 Metabolite 50 Mirapexin 50 Provider Reimbursement 50 Imported Drugs 50 OvaDx 50 Metformin HCl 50 Gestiva TM 50 Dkt. 50 Preterm Labor 50 calcitonin salmon 50 Proposed Regulations 50 Proxy Proposals 50 Adverse Reactions 50 Genetically Modified Salmon 50 MVEIRB 50 NUREG 49 Zolpimist 49 Suprax R 49 Sources Sought 49 Interrogatories 49 Lung Cancer Drug 49 Patent Invalid 49 Conscience Clause 49 PDUFA Prescription Drug 49 Amnesteem 49 Act PDUFA date 49 HCl Injection 49 Adversary Complaint 49 Third Amended Complaint 49 MVLWB 49 Keppra ® XR 49 WITH PREJUDICE 49 DNAwithPap TM Test 49 TNF blocker 49 Doc. # 49 ONGLYZA ™ 49 Taro Receives 49 buccal tablets 49 balsalazide disodium 49 CorePharma LLC 49 Receives Milestone Payment 49 Patent Litigation 49 desvenlafaxine 49 Pending Acquisition 49 reexamination proceedings 49 Migraine Drug 49 Extended Release Capsules 49 Javelin Pharma 49 Sirius XM Merger 49 VALSTAR 49 Hatch Waxman litigation 49 Amgen Nplate 49 FDA Endocrinologic 49 Tenn. R. Civ 49 KV Pharmaceuticals 49 Oracea R 49 Prostate Cancer Vaccine 49 Petition 49 Serious Side Effects 49 Has Been Filed 49 Contempt Order 49 Doc. No. 49 Oncologic Drugs Advisory 49 Declaratory 49 Iressa gefitinib 49 Saffran patent 49 PROVIGIL 49 Focetria 49 HepaGam B 49 RECOTHROM R 49 License Application 49 submitted supplemental Biologics 49 Undisputed Facts 49 DORIBAX 49 Nasdaq Deficiency Notice 49 Dalbavancin 49 Diet Supplement 49 Mirtazapine 49 Authorized Generics 49 FACTIVE R gemifloxacin 49 Granted Orphan Drug 49 PROTONIX 49 ANDAs 49 Sparlon 49 Rheumatoid Arthritis Drug 49 NYSE MYL 49 Aplenzin 49 Prescribing Information 49 Release Capsules 49 rabeprazole 49 NYSE MRX 49 Myfortic 49 Regulate Tobacco 49 Intellipharmaceutics 49 Par Pharma 49 Patent Covering 49 nonfinal 49 Writ Petition 49 sitagliptin phosphate 49 Tygacil 49 #mg Tablets [002] 49 Blood Pressure Drug 49 FOLOTYN ® 49 ZEGERID Capsules 49 counterclaims asserted 49 Gestiva 49 Waiver Request 49 Wins Patent Infringement 49 Rosiglitazone 49 Diet Pill 49 Patent Infringement Case 49 Cethromycin 49 Teva Parenteral Medicines 49 Zarnestra 49 NOXAFIL 49 Impax ANDA 49 Hydrochloride tablets 49 Systemic Delivery 49 dispositive motions 49 Azathioprine 49 License Option Agreement 49 Summary Judgment Motion 49 Substantial Shareholding 49 Somatuline R Autogel R 49 Emezine R 49 Ramelteon 49 granted Ortec 49 Applications ANDA 49 Tafas v. Doll 49 Focalin XR ® 49 Methylnaltrexone 49 Desloratadine 49 BiDil XR 49 OTC ZEGERID 49 Idenix Novartis 49 Antidepressant Drug 49 BioDelivery 49 Drug Administration Oncologic Drugs 49 Generic Lipitor 49 Mutual Recognition Procedure 49 v. Kappos 49 Ampligen r 49 Auxilium Pharma 49 Nicomide 49 Itraconazole 49 #mg dosage [001] 49 Vimpat R 49 eprodisate KIACTA TM 49 EGRIFTA TM 49 peremptory writ 49 Revised Proposal 49 liprotamase 49 Risk Minimization Action 49 Processes ACNFP 49 Nasdaq OSCI 49 VIVITROL ® 49 CLIA waived status 49 NitroMist 49 Tenofovir Disoproxil Fumarate 49 Avastin bevacizumab 49 SYCREST 49 Resubmit 49 anti SLAPP motion 49 Director Shareholding 49 EMBEDA 49 NUEDEXTA ™ 49 Pentasa 49 Boxed Warning 49 Premerger Notification 49 Heartburn Drugs 49 Focalin XR 49 Amicus briefs 49 Bazedoxifene 49 ANDA 49 Anemia Drugs 49 Upsher Smith 49 FFDCA 49 Aztreonam Lysine 49 Injunctive Relief 49 Receives Unsolicited 49 Zyflo CR 49 Initiates Enrollment 48 Teva ANDA 48 Phase 2a Trial 48 Doc. 48 Fortovase 48 SFDA Approval 48 telavancin NDA 48 Dapoxetine 48 Saforis 48 SURFAXIN 48 Firazyr 48 orphan designation 48 Nabi HB Intravenous 48 Liprotamase 48 Glybera R 48 efalizumab 48 testosterone gel LibiGel 48 Docket # 48 Tablets #mg [002] 48 Extended Release 48 Telavancin 48 Novopharm 48 mem. op 48 GMP Certificate 48 Intervenor 48 ACLJ amicus brief 48 Submits Biologics License Application 48 OMP designation 48 Settle Patent Litigation 48 ALJ Initial Determination 48 Milestone Payment From 48 Omapro 48 Doribax 48 PhotoCure 48 Tredaptive 48 Reexamination 48 Zalbin 48 Silicone Breast Implants 48 Blood Thinner 48 BPAI 48 INTUNIV TM 48 pulls Darvon painkiller 48 Receives Fast Track 48 Fampyra 48 Material Fact 48 Sycrest 48 AZILECT ® 48 Liver Toxicity 48 #k Clearance 48 OMAPRO ™ 48 Dismiss Lawsuit 48 Synerx 48 Nationwide Voluntary Recall 48 ADJUDGED 48 Waiver Agreement 48 Raptiva R 48 generic Lovenox 48 Osteoporosis Drug 48 Oscient Pharmaceuticals 48 PrevOnco 48 Sestamibi 48 TOPROL XL 48 Zenpep 48 Stipulated Order 48 ARIXTRA R 48 Drug Coated Stent 48 Fablyn 48 PHARMACIA 48 PDUFA date 48 EFFECTIVE DATE 48 Drugs Advisory 48 Kombiglyze XR 48 Parliamentary Standing Orders 48 Wellbutrin XL R 48 CrR #.# 48 Fenofibrate 48 CHMP recommendation 48 Similac Recall 48 Levocetirizine 48 balsalazide 48 Interpretative Communication 48 Valortim TM 48 Cladribine 48 DCGI 48 MEVACOR 48 rosuvastatin calcium 48 SEASONIQUE TM 48 XM Sirius Merger 48 exparte application 48 Patent Disputes 48 Drug Fails 48 Mofcom 48 SPARLON 48 Glycopyrrolate 48 GRAS status 48 Hatch Waxman Act 48 R vancomycin hydrochloride 48 Mycophenolate Mofetil 48 Estratest 48 Listings Qualifications Panel 48 Noxafil 48 Whistleblower Suit 48 Cholesterol Drugs 48 Oral Argument 48 Janssen Ortho Inc. 48 Methylin 48 JK Sucralose 48 Dissident Proxy Circular 48 Drug Candidate 48 ZEFTERA TM 48 Unsolicited Acquisition 48 Quo Warranto 48 ulipristal acetate 48 Voluntarily Withdraws 48 Application MAA 48 Schiavo Feeding Tube 48 Multaq dronedarone 48 Preliminary Objection 48 Periostat R 48 Zicam Cold Remedy Swabs 48 PRNewswire FirstCall Barr Pharmaceuticals 48 Review Strategic Alternatives 48 Single Dose 48 Fast Track Designation 48 sNDA submission 48 VISICOL R 48 FDA Orphan Drug 48 AstraZeneca Symbicort 48 Shareholder Meeting Date 48 Evista raloxifene 48 END FOOTNOTE 48 EXALGO 48 NASDAQ CHTT 48 Patent Infringement Claims 48 PCRA petition 48 GTC recombinant form 48 Specials Uncategorized 48 PRRB 48 Biogen Elan 48 enoxaparin sodium injection 48 AMAG Pharma 48 Dabigatran etexilate 48 KV Pharma 48 ex parte application 48 Pomerantz Law Firm 48 Completes Patient Enrollment 48 Daytrana ® 48 Company Nasdaq PRGO 48 Soriatane 48 Rofecoxib 48 Acne Medication 48 Present Preclinical Data 48 abacavir sulfate lamivudine 48 User Fee Act 48 Oral Solution 48 advocate Ajay Agrawal 48 Fifth Amended 48 Arbitration Agreements 48 indiplon capsules 48 Hepatitis B Vaccine 48 Patented Medicines Notice 48 Genzyme Myozyme 48 MK #B 48 Ofloxacin 48 MR Civ 48 ZEGERID OTC 48 IG HCR ;) CO 48 Tris Pharma 48 Cerepro ® 48 Patent Infringement Claim 48 Afluria 48 Tablets sodium phosphate 48 proposed rulemaking NPRM 48 TYGACIL 48 Contaminated Heparin 48 Enemy Combatant Case 48 RBXLF 48 XIENCE TM 48 rabeprazole sodium 48 Ltd Therapeutic Competitors 48 Inc. OTCBB VODG 48 Orally Disintegrating Tablets 48 Ampligen 48 Novel Foods 48 Humira adalimumab 48 Ortho Dermatologics 48 ATPace TM 48 Adenuric R 48 Charles M. Caprariello 48 Nasacort 48 Patent Infringement Lawsuit Against 48 Files Patent Infringement 48 granisetron formulated 48 Mircette 48 Javelin Pharmaceuticals 48 Pain Medication 47 Drug Administration FDA Endocrinologic 47 FIRAZYR 47 Receives Orphan Drug Designation 47 Corrective Action Order 47 Cefprozil 47 HCl capsules 47 Bifeprunox 47 balsalazide disodium Capsules 47 Indomethacin 47 NCUC 47 Immunomedics Announces 47 PIX# trial 47 PrandiMet 47 Vigorously Defend 47 Altabax 47 Initial Determination 47 Paladin Labs Inc. 47 therefore therapeutically equivalent 47 sNDAs 47 Substantial Shareholder Interest 47 Telzir 47 Sanctura XR 47 Shareholder Letter 47 Dendreon Provenge 47 Gestiva ™ 47 Initiates Clinical 47 AstraZeneca Iressa 47 RAZADYNE 47 Muraglitazar 47 Investigational Device Exemption 47 USFDA 47 Fibrocell Science Inc. 47 Carbidopa Levodopa 47 Nasal Spray 47 Provisional Patent 47 TOPAMAX R 47 Aciphex R 47 Directorate TPD 47 ethinyl estradiol tablets 47 amicus curiae briefs 47 Draft EIR 47 5 HT3 antagonist 47 Botox Botox Cosmetic 47 Esbriet ® 47 Asthma Medication 47 Tekturna HCT ® 47 Nasdaq ICOS 47 NEBIDO 47 Stockholder Vote 47 ibuprofen Injection 47 Liver Damage 47 Court Dismisses Lawsuit 47 Announces Favorable Ruling 47 MAA submission 47 Marketing Approval PMA 47 Misleading Advertising 47 No Objection Letter 47 Nasdaq RPRX 47 FDA Approvals 47 Dr. Gulfo 47 Hearings Panel 47 Focalin XR R 47 MHLW 47 Ophthalmic Drugs Advisory 47 SANVAR 47 markets HP Acthar 47 Oral Calcitonin 47 Spears Conservatorship 47 Endeavor Drug Eluting 47 Listing Application 47 midodrine 47 Shareholder Suits 47 Oxybutynin 47 Patent Spat 47 Potential Delisting 47 Patent Infringement Suit Against 47 clopidogrel bisulfate 47 Novartis Prexige 47 Octreotide 47 Teikoku Pharma USA 47 Shareholder Vote 47 Gene Variants 47 Eszopiclone 47 JUSTICE STEVENS 47 Exocrine Pancreatic Insufficiency 47 Patent Suit 47 LSA CCP art 47 Oxcarbazepine 47 Plaintiffs Counsel 47 Levoleucovorin 47 Receives CE Marking 47 Partnering Agreements 47 Sanvar R 47 Protalix BioTherapeutics 47 Low Doses 47 mesylate 47 conjugated estrogens 47 Luveniq 47 Low Dose 47 Anti Clotting Drug 47 Countersuit 47 OLEPTRO 47 Reduce Sodium 47 First Patient Enrolled 47 Preliminary Findings 47 Receives Favorable 47 liver resection surgeries 47 OTC IPXL today 47 Medicis Pharmaceutical Corporation 47 Silodosin 47 Egrifta 47 Rhucin R 47 Unsolicited Offer 47 FDA Pulmonary Allergy 47 generic Norvasc 47 Cenestin 47 Unanimously Recommends 47 Abacavir Sulfate 47 Creditor Protection 47 Limine 47 Alphapharm 47 Zirgan 47 AMRIX 47 NASDAQ Deficiency Notice 47 amlodipine besylate 47 subsidiary Duramed Pharmaceuticals 47 Supplementary Prospectus 47 dkt 47 PRIALT 47 Humenza 47 fentanyl transdermal system 47 Rapaflo 47 Pulmonary Arterial Hypertension 47 reexaminations 47 Cold Medicines 47 CUSF application 47 Earns Milestone Payment 47 visit smith.com 47 Competitive Impact Statement 47 Intelence 47 Partial Birth 47 Sunesis Pharma 47 Inquiry NOI 47 Zidovudine Tablets 47 Dissenting Opinion 47 Abortion Pill 47 FDA Antiviral Drugs 47 Employment Inducement Awards 47 Natural Resources MinAmb 47 autologous cellular immunotherapy 47 Rotarix R 47 CEPHALON 47 Heart Stents 47 Alito Nomination 47 prosecution laches 47 orally disintegrating 47 GRAS affirmation 47 Listing Deficiency 47 bazedoxifene 47 preliminary injunctive relief 47 Tostrex 47 CryoSeal FS System 47 Applicant Guidebook 47 Shareholder Lawsuit 47 VCRT 47 naproxen esomeprazole magnesium 47 amici briefs 47 Invalidation 47 Risperidone 47 Therapeutic Competitors Companies 47 DC Handgun Ban 47 Exelbine NDA 47 Key Milestones 47 INAMED 47 Sankyo Pharma Inc. 47 SOLODYN 47 PRAECIS PHARMACEUTICALS INCORPORATED 47 Lamivudine 47 octreotide acetate 47 Mini Tender Offer 47 TRELSTAR R 47 Ranexa R 47 ULDAGE 47 GRALISE